g
wang
v
l
b
l
e
w
w
w
c
e
n
c
e
r
e
c
c
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
r
e
respiratori
medicin
see
front
matter
result
antiwei
increas
patient
recoveri
p
reduc
sever
ill
measur
median
symptom
score
p
influenzalik
influenzaconfirm
popul
compar
placebo
influenzaconfirm
patient
report
reduct
sever
fever
p
z
cough
p
z
expector
p
z
oneday
treatment
antiwei
compar
placebo
advers
event
profil
similar
antiwei
placebo
conclus
antiwei
effect
well
toler
treatment
natur
influenza
infect
adult
antiwei
repres
clinic
valuabl
intervent
manag
influenza
tradit
chines
herb
influenza
random
control
trial
summari
object
investig
efficaci
safeti
antiwei
tradit
chines
prescript
treatment
influenza
method
multicent
random
doubleblind
placebocontrol
trial
recruit
adult
age
year
within
h
onset
influenzalik
symptom
patient
confirm
influenza
elig
patient
randomli
assign
g
antiwei
n
z
placebo
n
z
twice
daili
three
day
patient
record
temperatur
symptom
diari
card
treatment
analys
perform
influenzalik
popul
influenzaconfirm
popul
influenza
caus
infect
either
influenza
b
virus
one
common
import
respiratori
ill
affect
age
uncompl
influenza
gener
resolv
period
although
cough
malais
persist
week
influenza
epidem
influenza
pandem
first
pandem
sinc
associ
increas
morbid
hospit
rate
excess
mortal
within
vulner
popul
includ
elderli
infant
underli
medic
condit
although
drug
adamantan
ie
amantadin
rimantadin
neuraminidas
inhibitor
ie
oseltamivir
zanamivir
avail
treat
prevent
influenza
recent
emerg
adamantan
resist
strain
render
agent
less
effect
addit
sporad
case
oseltamivirresist
influenza
viru
infect
report
worldwid
follow
pandem
even
though
vaccin
strategi
influenza
viru
present
china
patient
may
look
beyond
convent
treatment
consid
complementari
altern
medicin
includ
tradit
chines
medicin
tcm
situat
tcm
repres
one
aspect
chines
medic
philosophi
character
emphasi
maintain
restor
balanc
chines
medicin
herb
import
compon
tcm
deriv
plant
usual
incorpor
one
herb
basic
drug
treat
diseas
supplement
use
chines
medicin
herb
found
benefici
manag
sever
acut
respiratori
syndrom
sar
base
supplementari
treatment
chines
medicin
herb
might
also
show
promis
treat
prevent
influenza
influenzalik
ill
random
control
trial
rct
publish
evid
treat
prevent
influenza
tcm
yet
convincingli
establish
due
poor
report
qualiti
small
sampl
size
antiwei
granul
tradit
chines
prescript
consist
mahuang
herba
ephedra
baimaogeng
rhizoma
imperata
gegen
radix
pueraria
guizhi
ramulu
cinnamoumum
kuxingren
semen
armeniaca
amarum
ganjiang
rhizoma
zingiberi
gancao
radix
glycyrrhiza
one
gram
antiwei
granul
equal
g
crude
drug
resourc
pharmacolog
action
compon
formula
list
tabl
accord
tcm
mahuang
baimaogen
formula
regard
princip
herb
could
reliev
exterior
disord
defervesc
gegen
guizhi
serv
minist
cooper
princip
reliev
exterior
syndrom
defervesc
kuxingren
ganjiang
adjuv
drug
open
inhibit
lungenergi
regul
flow
qi
elimin
phlegm
reliev
cough
gancao
serv
guid
drug
moisten
lung
arrest
cough
coordin
drug
action
formula
antiwei
use
wide
base
clinic
experi
rather
evid
rct
treatment
influenzalik
ill
fever
headach
pain
cough
china
therefor
prospect
multicent
random
doubleblind
placebocontrol
clinic
trial
undertaken
investig
efficaci
safeti
antiwei
granul
treatment
natur
acquir
influenza
human
patient
ethic
elig
patient
present
fever
c
least
one
respiratori
symptom
cough
sore
throat
nasal
symptom
least
one
constitut
symptom
headach
fatigu
myalgia
thirst
chill
recruit
emerg
depart
januari
june
inclus
criteria
follow
clinic
diagnosi
influenza
age
year
within
h
onset
influenzalik
ill
written
inform
consent
exclus
criteria
follow
treatment
onset
influenzalik
ill
confirm
upper
respiratori
viral
infect
suspect
bacteri
infect
base
symptom
leukocyt
count
l
neutrophil
granulocyt
pregnanc
breastfeed
allergi
food
addit
drug
compon
antiwei
granul
current
alcohol
drug
abus
sever
diseas
cardiac
respiratori
hepat
renal
central
nervou
system
haematopoiet
system
cancer
inabl
understand
complet
studi
current
psychiatr
ill
dementia
clinic
import
chronic
ill
known
hiv
infect
receiv
steroid
immunosuppress
vaccin
influenza
previou
month
also
requir
patient
childbear
age
use
contracept
reduc
heat
case
exterior
syndrom
fever
pain
stiff
back
nape
reliev
thirst
febril
diseas
diabet
mellitu
arrest
diarrhea
spleen
insuffici
promot
erupt
measl
guizhi
die
young
stem
cinnamomum
cassia
presl
famili
lauracea
induc
sweat
releas
muscl
case
windcold
afflict
warm
unblock
meridian
reliev
variou
pain
due
cold
congeal
blood
stimul
menstrual
discharg
treat
amenorrhea
replenish
qi
tonifi
heat
treat
arrhythmia
case
heart
qi
defici
tonifi
spleen
treat
lassitud
anorexia
loos
bowel
case
spleen
insuffici
reliev
epigastr
colic
spastic
pain
limb
dispel
phlegm
arrest
cough
clear
heat
counteract
toxin
treat
sore
throat
boil
sore
drug
overdos
frequent
modul
ingredi
prescript
data
classifi
dictionari
tradit
chines
medicin
zhufan
xie
medic
ethic
committe
west
china
hospit
sichuan
univers
approv
studi
accord
recent
principl
declar
helsinki
patient
gave
inform
consent
free
withdraw
studi
time
prospect
multiplecent
random
doubleblind
placebocontrol
trial
undertaken
eight
chines
center
three
north
china
three
northeast
china
one
northwest
china
one
west
china
patient
random
doubleblind
fashion
receiv
either
antiwei
granul
placebo
random
code
gener
prco
plan
analysi
system
sa
version
window
alloc
detail
seal
envelop
unknown
investig
particip
studi
antiwei
placebo
suppli
tasli
group
tianjin
china
herbal
composit
antiwei
present
tabl
placebo
granul
compos
starch
bitter
agent
visual
indistinguish
antiwei
appear
color
size
packag
subject
antiwei
group
receiv
g
antiwei
granul
twice
day
three
day
wherea
patient
placebo
group
receiv
g
placebo
twice
day
three
day
patient
treat
equival
fashion
assess
complianc
daili
diari
card
review
return
medic
end
treatment
took
present
past
person
medic
histori
measur
vital
sign
temperatur
respir
rate
heart
rate
blood
pressur
physic
examin
pharynx
larynx
lung
respiratori
system
collect
baselin
virolog
sampl
treatment
accept
treatment
patient
record
axillari
temperatur
everi
h
h
day
one
day
record
axillari
temperatur
diari
card
exclud
respiratori
ill
subject
receiv
chest
xray
screen
begin
treatment
presenc
sever
influenza
symptom
includ
cough
sore
throat
nasal
obstruct
rhinorrhoea
headach
fatigu
myalgia
thirst
chill
record
daili
use
fourpoint
scale
absent
mild
moder
sever
first
record
perform
patient
admit
next
two
record
day
treatment
done
morn
influenza
confirm
direct
immunofluoresc
antibodi
assay
dfa
nasopharyng
swab
show
sensit
influenza
viru
influenza
b
viru
specif
influenza
viru
influenza
b
viru
treatment
assign
blind
virolog
test
done
west
china
hospit
sichuan
univers
chengdu
primari
endpoint
sever
ill
measur
mean
symptom
score
whole
treatment
period
number
recov
patient
intentionto
treat
influenzaconfirm
popul
recoveri
defin
absenc
fever
temperatur
c
nine
symptom
chill
headach
myalgia
nasal
obstruct
sore
throat
fatigu
cough
rhinorrhoea
expector
thirst
secondari
outcom
includ
length
time
allevi
fever
within
first
h
treatment
sever
symptom
rate
influenzavirusposit
convers
neg
influenzaconfirm
popul
entri
particip
requir
record
unexpect
sign
symptom
feel
treatment
period
routin
test
blood
urin
stool
well
hepat
renal
function
electrocardiogram
ecg
perform
admiss
treatment
assess
safeti
group
sampl
size
antiwei
group
placebo
group
ratio
calcul
accord
publish
data
power
greater
detect
differ
percent
recoveri
rate
assum
signific
level
sampl
size
calcul
perform
use
normal
approxim
wilcoxon
ranksum
test
influenzalik
influenzaconfirm
popul
analyz
influenzalik
popul
consist
random
patient
receiv
least
one
dose
medic
studi
safeti
analys
perform
popul
includ
patient
receiv
least
one
dose
medic
least
one
followup
safeti
whether
withdrawn
prematur
analys
perform
use
stata
measur
data
show
normal
distribut
describ
mean
ae
standard
deviat
analyz
analysi
varianc
determin
differ
antiwei
placebo
group
measur
data
show
nonnorm
distribut
describ
median
analyz
wilcoxon
ranksum
test
frequenc
data
analyz
use
chisquar
c
fisher
test
primari
endpoint
analyz
use
surviv
method
kaplanemei
curv
construct
significancetest
use
logrank
method
mean
symptom
score
use
analysi
varianc
rate
influenzavirusposit
convers
neg
compar
differ
group
c
test
p
twotail
test
consid
signific
total
elig
patient
enrol
randomli
assign
receiv
antiwei
granul
n
z
placebo
n
z
patient
withdrew
studi
earli
sever
reason
includ
lost
followup
antiwei
n
z
placebo
n
z
protocol
violat
antiwei
n
z
placebo
n
z
refus
continu
antiwei
n
z
placebo
n
z
overal
patient
laboratoryconfirm
influenza
fig
influenza
influenza
b
influenza
b
tabl
avail
data
patient
includ
efficaci
safeti
analys
differ
observ
two
group
demograph
clinic
characterist
safeti
studi
drug
assess
patient
influenzaconfirm
patient
antiwei
result
significantli
patient
recov
show
reduct
sever
ill
number
patient
recov
three
day
treatment
antiwei
group
p
z
fig
compar
placebo
group
benefit
also
seen
patient
influenzalik
diseas
vs
p
similarli
antiwei
result
signific
reduct
total
symptom
score
three
day
treatment
influenzaconfirm
popul
ae
vs
ae
p
influenzalik
popul
ae
vs
ae
p
compar
placebo
oneday
treatment
improv
percentag
symptom
score
differ
symptom
score
baselin
oneday
treatment
divid
symptom
score
baselin
fever
vs
p
z
cough
vs
p
z
expector
vs
p
z
significantli
reduc
antiwei
group
compar
placebo
influenzaconfirm
patient
statist
signific
reduct
seen
sever
chill
vs
fig
time
median
temperatur
fell
c
baselin
antiwei
group
c
placebo
group
p
z
treatment
benefit
fever
appar
earli
h
start
treatment
fig
antiwei
treatment
result
patient
becom
afebril
within
h
compar
placebo
p
z
influenzaconfirm
popul
influenza
viru
decreas
antiwei
group
placebo
group
three
day
treatment
p
z
fig
complianc
medic
high
treatment
group
major
patient
n
z
record
take
medic
antiwei
gener
well
toler
compar
placebo
increas
withdraw
rate
advers
event
one
patient
given
antiwei
report
mild
paroxysm
palpit
resolv
within
two
day
result
withdraw
studi
laboratori
result
ecg
vital
sign
differ
significantli
baselin
two
group
patient
includ
studi
came
epidem
region
influenza
season
dfa
screen
nasopharyng
swab
posit
rate
studi
slightli
lower
zambon
studi
oral
administr
g
antiwei
twice
daili
associ
signific
clinic
antivir
effect
healthi
adult
natur
occur
influenza
given
within
h
onset
gener
well
toler
patient
influenzalik
ill
number
recov
patient
three
day
treatment
antiwei
group
increas
sever
symptom
significantli
reduc
compar
placebo
oneday
treatment
antiwei
benefit
reduc
fever
appar
two
key
symptom
cough
expector
significantli
improv
end
treatment
time
antiwei
well
toler
safeti
similar
placebo
sinc
introduct
tcm
world
debat
regard
role
herbal
medicin
therapi
ill
influenza
infect
accord
treatis
coldinduc
diseas
shang
han
lun
varieti
herbal
formula
use
treat
patient
infecti
diseas
year
chines
medicin
wide
accept
amongst
chines
popul
use
chines
medicin
treat
pandem
endem
diseas
long
describ
tradit
medic
book
shang
han
lun
huangdi
canon
medicin
huangdi
nei
jing
prescript
infecti
diseas
made
base
clinic
present
rather
laboratoryconfirm
pathogen
beyond
knowledg
time
small
fraction
thousand
medicin
plant
use
worldwid
test
rigor
random
placebocontrol
trial
yet
random
control
trial
best
way
demonstr
efficaci
medic
herbal
convent
therapi
although
herb
herbal
product
part
complementari
altern
therapi
propos
effect
treat
prevent
influenza
establish
beyond
reason
doubt
extract
elderberri
use
treat
influenza
past
two
studi
demonstr
signific
benefit
herbal
product
prophylaxi
viral
infect
herbal
supplement
user
also
report
signific
improv
influenzalik
symptom
chill
cough
fatigu
headach
qualityoflif
measur
mental
health
score
studi
figur
improv
percentag
symptom
score
oneday
treatment
influenzacomfirm
patient
p
placebo
vs
antiwei
improv
percentag
symptom
score
defin
differ
symptom
score
baselin
oneday
treatment
divid
symptom
score
baselin
varieti
chines
herb
wide
use
antipyret
drug
clear
accumul
heat
lung
accord
theori
tcm
one
recent
studi
kubo
et
al
show
antipyret
effect
maoto
japanes
herbal
medicin
treatment
type
influenza
infect
children
comparison
oseltamivir
japanes
tradit
herbal
medicin
includ
mahuang
guizhi
kuxingren
gancao
compon
includ
antiwei
studi
antipyret
effect
appar
within
h
antiwei
administr
influenza
symptom
gener
troublesom
although
assess
econom
effect
indirect
cost
influenza
workplac
absente
perform
work
could
improv
accord
clinic
benefit
observ
influenzaconfirm
popul
popul
influenzalik
ill
studi
anim
experi
vitro
confirm
antiwei
inhibit
growth
varieti
viru
includ
influenza
b
respiratori
syncyti
viru
rsv
adenoviru
etc
data
shown
show
antiwei
significantli
reduc
posit
rate
influenza
viru
treatment
find
consist
result
studi
antivir
drug
influenza
selflimit
viral
diseas
increas
therapeut
benefit
obtain
treatment
start
earli
possibl
symptom
onset
durat
cough
expector
shorter
sever
two
symptom
gener
lower
antiwei
group
data
shown
influenza
transmit
virusladen
secret
cough
expector
could
distress
symptom
influenza
also
contribut
spread
infect
patient
receiv
antiwei
significantli
lower
posit
rate
viru
laryngopharynx
swab
placebo
group
differ
togeth
improv
symptom
includ
cough
expector
may
help
reduc
transmiss
viru
antiwei
gener
well
toler
almost
advers
event
report
one
patient
given
antiwei
report
mild
paroxysm
palpit
resolv
within
two
day
without
addit
treatment
symptom
associ
discontinu
rate
antiwei
group
compar
placebo
advers
effect
abnorm
laboratori
test
associ
antiwei
treatment
must
note
antiwei
contain
mahuang
report
side
effect
chest
pain
hypertens
arrhythmia
myocardi
infarct
stroke
death
serv
dietari
supplement
weight
reduct
perform
enhanc
use
mahuang
studi
associ
signific
advers
event
prescript
g
antiwei
equal
g
crude
herb
g
mahuang
daili
dose
mahuang
g
small
dosag
compar
convent
dose
tcm
treatment
recogn
studi
potenti
limit
includ
followup
treatment
symptom
influenza
observ
day
thu
end
studi
mani
patient
fulli
recov
therefor
durat
ill
time
allevi
could
exactli
evalu
addit
protocol
specif
exclud
individu
medic
condit
would
place
highrisk
popul
often
associ
sever
influenza
conclus
studi
clearli
indic
antiwei
effect
treatment
influenzaconfirm
influenzalik
ill
otherwis
healthi
adult
antiwei
provid
altern
convent
treatment
influenza
influenzalik
symptom
antiwei
might
also
potent
medic
use
influenza
pandem
situat
shortag
antivir
agent
vaccin
exist
find
provid
rational
continu
studi
agent
treatment
influenza
includ
studi
children
highrisk
popul
largescal
studi
investig
antivir
effect
antiwei
studi
mechan
also
requir
